Giulia Baciarello

Villejuif, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 28, 2025

Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.

Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.

Journal: JCO precision oncology

Published: August 07, 2025

Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancer.

Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancer.

Journal: Communications medicine

Published: March 14, 2025

Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings.

Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings.

Journal: Frontiers in oncology

Published: September 04, 2024

Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.

Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.

Journal: Cell death & disease

Published: February 14, 2024

Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma.

Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: April 17, 2023

Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.

Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.

Journal: Cancers

Published: January 03, 2023

Urachal carcinoma: a large retrospective multicentric study from the French Genito-Urinary Tumor Group.

Urachal carcinoma: a large retrospective multicentric study from the French Genito-Urinary Tumor Group.

Journal: Frontiers in oncology

Published: November 28, 2022

Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 18, 2022

PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.

PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.

Journal: Drugs

Published: March 10, 2022

Biomarker-driven immunotherapy for precision medicine in prostate cancer.

Biomarker-driven immunotherapy for precision medicine in prostate cancer.

Journal: Personalized medicine

Published: December 07, 2021

Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.

Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.

Journal: International journal of radiation oncology, biology, physics

Published: December 03, 2021

Showing 1-12 of 44

Last Updated: 09/26/2026